EX-8.1 4 azn-20221231xex8d1.htm EXHIBIT 8.1

Exhibit 8.1

GROUP SUBSIDIARIES*

At December 31, 2022

    

Country

    

Percentage of voting
share capital held

Wholly owned subsidiaries

 

 

Alexion Pharmaceuticals, Inc.

United States

100

Alexion Pharma International Operations Limited

Ireland

100

AstraZeneca AB

Sweden

100

AstraZeneca Biotech AB

Sweden

100

AstraZeneca Dunkerque Production SCS

France

100

AstraZeneca Finance and Holdings Inc.

United States

100

AstraZeneca Intermediate Holdings Limited

England

100

AstraZeneca Pharmaceuticals Co., Limited

China

100

AstraZeneca Pharmaceuticals LP

United States

100

AstraZeneca Treasury Limited

England

100

AstraZeneca UK Limited

England

100

AstraZeneca (Wuxi) Trading Co. Ltd

China

100

IPR Pharmaceuticals, Inc.

Puerto Rico

100

MedImmune, LLC

United States

100


Subsidiary companies which would be deemed to be a “significant subsidiary” in accordance with rule 1-02(w) of Regulation S-X as at December 31, 2022.